AxoGen, Inc. (AXGN) has a market capitalization of $1.79B and trades at $34.46. The 52-week range is 9.22-36.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -101.4, Earnings Per Share (EPS) of $-0.34, annual revenue of $225.21M.
The stock has a beta of 0.98, operates in the Healthcare sector.
